Cargando…
MNX1 reduces sensitivity to anoikis by activating TrkB in human glioma cells
Glioma is the most common type of malignant intracranial tumor in adults and is associated with the highest mortality rate. Although surgery, radiotherapy, chemotherapy and other treatment methods have progressed, the median survival of patients with glioma is only 14–15 months. Glioma cells are abl...
Autores principales: | Jiang, Lai, Chen, Shaojun, Zhao, Donggang, Yan, Jun, Chen, Jiemin, Yang, Chunlin, Zheng, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102707/ https://www.ncbi.nlm.nih.gov/pubmed/30066929 http://dx.doi.org/10.3892/mmr.2018.9329 |
Ejemplares similares
-
Upregulation of TrkB Promotes Epithelial-Mesenchymal Transition and Anoikis Resistance in Endometrial Carcinoma
por: Bao, Wei, et al.
Publicado: (2013) -
Proliferative role of BDNF/TrkB signaling is associated with anoikis resistance in cervical cancer
por: Yuan, Yuan, et al.
Publicado: (2018) -
Imbalance of neurotrophin receptor isoforms TrkB-FL/TrkB-T1 induces neuronal death in excitotoxicity
por: Vidaurre, Ó G, et al.
Publicado: (2012) -
Do Small Molecules Activate the TrkB Receptor in the Same Manner as BDNF? Limitations of Published TrkB Low Molecular Agonists and Screening for Novel TrkB Orthosteric Agonists
por: Pankiewicz, Piotr, et al.
Publicado: (2021) -
TrkB-Targeted Therapy for Mucoepidermoid Carcinoma
por: Wagner, Vivian P., et al.
Publicado: (2020)